ZBH stock icon

Zimmer Biomet

104.95 USD
-0.51
0.48%
At close Oct 17, 4:00 PM EDT
After hours
105.18
+0.23
0.22%
1 day
-0.48%
5 days
1.64%
1 month
-1.21%
3 months
-5.49%
6 months
-13.48%
Year to date
-13.54%
1 year
-1.54%
5 years
-24.23%
 

About: Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Employees: 18,000

0
Funds holding %
of 6,740 funds
0
Analysts bullish %
of 18 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0% less funds holding

Funds holding: 992 [Q1] → 989 (-3) [Q2]

3% less first-time investments, than exits

New positions opened: 92 | Existing positions closed: 95

2.57% less ownership

Funds ownership: 92.92% [Q1] → 90.35% (-2.57%) [Q2]

11% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 8 (-1) [Q2]

17% less capital invested

Capital invested by funds: $24.4B [Q1] → $20.2B (-$4.25B) [Q2]

25% less repeat investments, than reductions

Existing positions increased: 299 | Existing positions reduced: 399

38% less call options, than puts

Call options by funds: $45.4M | Put options by funds: $73.6M

Research analyst outlook

18 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$107
2%
upside
Avg. target
$122
16%
upside
High target
$145
38%
upside

18 analyst ratings

positive
44%
neutral
50%
negative
6%
Oppenheimer
Steven Lichtman
65% 1-year accuracy
11 / 17 met price target
29%upside
$135
Outperform
Maintained
15 Oct 2024
Raymond James
Jayson Bedford
58% 1-year accuracy
18 / 31 met price target
17%upside
$123
Outperform
Maintained
14 Oct 2024
RBC Capital
Shagun Singh
66% 1-year accuracy
27 / 41 met price target
14%upside
$120
Outperform
Maintained
8 Oct 2024
BTIG
Ryan Zimmerman
74% 1-year accuracy
28 / 38 met price target
20%upside
$126
Buy
Maintained
3 Oct 2024
Evercore ISI Group
Vijay Kumar
74% 1-year accuracy
28 / 38 met price target
5%upside
$110
In-Line
Maintained
1 Oct 2024

Financial journalist opinion

Based on 4 articles about ZBH published over the past 30 days

Charts implemented using Lightweight Charts™